← Leaderboards
Katherine Jean Wert
Whitehead Institute For Biomedical Res
$1,371,752
Attributed
$1,597,252
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,597,252 · 4
By mechanism
R01$1,020,723 · 2
R21$451,000 · 1
F32$125,529 · 1
Top collaborators
- Amanda Kathleen Casey1 shared
Most similar at Whitehead Institute For Biomedical Res
Same institution · by research overlap
- X. Shawn Liu$4,173,782
- Wei Tong$21,627,247
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCellsMouse ModelSignal TransductionTherapeutic TargetPlayBiological ModelsPredispositionGenesStem CellsNovel StrategiesInnovationCoupledCessation Of LifeEmbryonic DevelopmentLaboratoriesComplexAdolescentAffectAreaChimera OrganismCuesCancer EtiologyCancer Biology
Grant awards (6)
The Relationship Between Sex and Progression of Retinal Degenerative Disease$543,614
R01 · FY2025 · EY · contact PI
Gene Regulation Underlying Photoreceptor Neurodegeneration$477,109
R01 · FY2025 · EY · contact PI
Regulation of retinal homeostasis and disease by Fic-mediated AMPylation$451,000
R21 · FY2023 · EY
A novel in vivo model system of melanoma using a human-mouse neural crest cell chimera$17,005
F32 · FY2017 · CA · contact PI
A novel in vivo model system of melanoma using a human-mouse neural crest cell chimera$56,118
F32 · FY2016 · CA · contact PI
A novel in vivo model system of melanoma using a human-mouse neural crest cell chimera$52,406
F32 · FY2015 · CA · contact PI